Jan 24, 2023 | RRx Perspective
By Jonathan Male Pharmacovigilance caseloads have been rising due to increases in reported adverse events, with many sponsors bogged down by tracking large volumes of safety data using manual processes. As a result, an increasing number of biotech companies are now...
Nov 29, 2022 | Marketing Innovation, RRx Perspective
By Jonathan Male Several recent initiatives are aimed at advancing more equitable care for individuals and communities who are underserved. However, rare disease is an area where people are very often overlooked or misunderstood. Many of us want to change that...
Sep 20, 2022 | Marketing Innovation, RRx Perspective
Why Small Healthcare Agencies Are the Answer By Jonathan Male Most healthcare agencies are consistently overpriced, always behind schedule, plus constantly overselling and under-delivering — and the bigger they are, the more expensive they are, the more slow-moving...
Jul 25, 2022 | RRx Perspective
Big things are happening in Texas in the field of nanomedicine. Backed by a four-year $2.1 million grant from the National Institutes of Health (NIH), the Bioengineering Department at the University of Texas at Arlington (UTA) is out to improve treatment for...
Jan 11, 2022 | Marketing Innovation, RRx Perspective
This year, expect the trend to continue of healthcare marketing focusing on brand planning, customer insights and market research to launch brands and increase market share. When was the last time you had more than a surface conversation with your customers? Evolved...
Nov 15, 2021 | Marketing Innovation, RRx Perspective
Thanks to increasing support from the United States government, clinicians, and the pharmaceutical industry, “precision medicine” is the new frontier of healthcare. In 2015, President Obama launched the Precision Medicine Initiative. This bold new effort provided...
